NasdaqCM:AXGNMedical Equipment
Assessing Axogen (AXGN) Valuation After A Strong 90 Day Share Price Gain
Recent performance snapshot and business context
Axogen (AXGN) shares recently moved, with the stock down about 3.1% over the past day but up roughly 7.1% over the past week, drawing fresh attention to this specialized nerve repair company.
Over the past month the stock is roughly flat, while the past 3 months show a gain of about 35.1%. For context, Axogen focuses on peripheral nerve regeneration products and generates revenue of about $238.1 million, while still reporting a net loss of...